Global Lice Treatment Market Size, Share, Forecast Report, 2020-2027

The Global Lice Treatment Market is expected to register a CAGR of 6.5% during the forecast period of 2018 to 2023. Lice are parasites that feed on human blood, mostly from the head and pubic areas. The medical condition can be infested to others by close contact with carrier or through pets. In recent years, the prevalence of head lice has increased, resulting in a parallel demand for therapeutics. According to an article published by the Centers for Disease Control and Prevention in 2015, it was estimated that ~6 million to 12 million infestations occur each year within the U.S. Moreover, the article further stated that most of the reported cases were for children who aged 3 to 11 years. Trends in the population composition, suggests that this susceptible population has increased. As per the international database of U.S. Census Bureau, there were ~3,416,831 children who aged 5-9 years within Germany. Thus, such high patient pool is projected to fuel the market.
Segmentation

The global lice treatment market is segmented based on type, treatment, end user, and region.

On the basis of type, the market is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. Based on treatment, the market is devised into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is sub-segmented into permethrin, pyrethrin, and others. The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By end user, the market is divided into hospitals & clinics, retail pharmacies, online platform. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.
Key players

Some of the key players in the global lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others

Market Segmentation and Key Market Players:

Global Lice treatment Market, by Type:

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

Global Lice Treatment Market, by Treatment:

• OTC Products
• Permethrin
• Pyrethrin
• Others

• Prescription Medications
• Ivermectin
• Spinosad
• Malathion
• Others

Global Lice treatment Market, by End-User:

• Hospitals & Clinics
• Retail Pharmacies
• Online Platform

Global Lice Treatment Market, by Key Players:

• AkzoNobel N.V.
• Alliance Pharmaceuticals Ltd.
• Bayer HealthCare
• Dow AgroSciences LLC
• Elanco
• GlaxoSmithKline
• Insight Pharmaceuticals
• Johnson & Johnson
• Omega Pharma
• Pfizer
• Sanofi
• Suven Life Sciences
• Taro Pharmaceuticals
• Topaz Pharmaceuticals Inc.